New potent sensitizers for photodynamic therapy : 21-oxaporphyrin, 21-thiaporphyrin and 21,23-dithiaporphyrin induce extensive tumor necrosis

New sensitizers for photodynamic therapy (PDT) are reported. These compounds, namely 21-thiaporphyrin, 21,23-dithiaporphyrin and 21-oxaporphyrin, reveal some of the properties required for such therapy. Their physicochemical, chemical and pharmacological features meant that we could use them in the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and clinical oncology 1999-10, Vol.125 (10), p.563-568
Main Authors: ZIOŁKOWSKI, P, SYMONOWICZ, K, CHMIELEWSKI, P, LATOS-GRAZYNSKI, L, STRECKYTE, G, ROTOMSKIS, R, RABCZYNSKI, J
Format: Article
Language:English
Subjects:
Animals
Biological and medical sciences
Fibrosarcoma - drug therapy
Medical sciences
Mice
Mice, Inbred BALB C
Necrosis
Photochemotherapy - methods
Photoradiation therapy and photosensitizing agent
Photosensitizing Agents - chemistry
Photosensitizing Agents - therapeutic use
Porphyrins - chemistry
Porphyrins - therapeutic use
Skin - pathology
Survival Analysis
Time Factors
Treatment with physical agents
Treatment. General aspects
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:New sensitizers for photodynamic therapy (PDT) are reported. These compounds, namely 21-thiaporphyrin, 21,23-dithiaporphyrin and 21-oxaporphyrin, reveal some of the properties required for such therapy. Their physicochemical, chemical and pharmacological features meant that we could use them in the treatment of transplantable BFS1 fibrosarcoma in Balb/c mice. New sensitizers and the well-known chlorin e6 (Ce6) were used in doses of 2.5, 5.0, 7.5 and 10.0 mg/kg body weight, given intraperitoneally and followed by light irradiation, the total light doses being 50, 100 and 150 J/cm(2) within 24 h after injection. The effectiveness of new sensitizers in PDT was evaluated with in terms of tumor necrosis intensity, the survival time of treated animals, the rate of tumor response (complete/partial/no response), and skin photosensitivity. These results were compared to results obtained in analogous conditions after Ce6-PDT. Distribution studies revealed that the highest concentration of new compounds occurred within 24 h after injection. The results of these experiments confirmed that 21-thiaporphyrin, 21,23-dithiaporphyrin and 21-oxaporphyrin can be considered as potent tumor photosensitizers that do not exert any unwanted effects, primarily skin photosensitization. We suggest that these porphyrins are possible sensitizers to be applied in clinical PDT.
ISSN:0171-5216
1432-1335
DOI:10.1007/s004320050317